File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.vaccine.2020.09.048
- Scopus: eid_2-s2.0-85092225370
- PMID: 33041103
- WOS: WOS:000627802900002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The disease burden of influenza beyond respiratory illness
Title | The disease burden of influenza beyond respiratory illness |
---|---|
Authors | |
Keywords | Burden of disease Cardiovascular events Comorbidity Complications Influenza virus Vaccination |
Issue Date | 2021 |
Citation | Vaccine, 2021, v. 39 suppl. 1, p. A6-A14 How to Cite? |
Abstract | Although influenza is primarily considered a respiratory infection and causes significant respiratory mortality, evidence suggests that influenza has an additional burden due to broader consequences of the illness. Some of these broader consequences include cardiovascular events, exacerbations of chronic underlying conditions, increased susceptibility to secondary bacterial infections, functional decline, and poor pregnancy outcomes, all of which may lead to an increased risk for hospitalization and death. Although it is methodologically difficult to measure these impacts, epidemiological and interventional study designs have evolved over recent decades to better take them into account. Recognizing these broader consequences of influenza virus infection is essential to determine the full burden of influenza among different subpopulations and the value of preventive approaches. In this review, we outline the main influenza complications and societal impacts beyond the classical respiratory symptoms of the disease. |
Persistent Identifier | http://hdl.handle.net/10722/311494 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.342 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Macias, Alejandro E. | - |
dc.contributor.author | McElhaney, Janet E. | - |
dc.contributor.author | Chaves, Sandra S. | - |
dc.contributor.author | Nealon, Joshua | - |
dc.contributor.author | Nunes, Marta C. | - |
dc.contributor.author | Samson, Sandrine I. | - |
dc.contributor.author | Seet, Bruce T. | - |
dc.contributor.author | Weinke, Thomas | - |
dc.contributor.author | Yu, Hongjie | - |
dc.date.accessioned | 2022-03-22T11:54:04Z | - |
dc.date.available | 2022-03-22T11:54:04Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Vaccine, 2021, v. 39 suppl. 1, p. A6-A14 | - |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | http://hdl.handle.net/10722/311494 | - |
dc.description.abstract | Although influenza is primarily considered a respiratory infection and causes significant respiratory mortality, evidence suggests that influenza has an additional burden due to broader consequences of the illness. Some of these broader consequences include cardiovascular events, exacerbations of chronic underlying conditions, increased susceptibility to secondary bacterial infections, functional decline, and poor pregnancy outcomes, all of which may lead to an increased risk for hospitalization and death. Although it is methodologically difficult to measure these impacts, epidemiological and interventional study designs have evolved over recent decades to better take them into account. Recognizing these broader consequences of influenza virus infection is essential to determine the full burden of influenza among different subpopulations and the value of preventive approaches. In this review, we outline the main influenza complications and societal impacts beyond the classical respiratory symptoms of the disease. | - |
dc.language | eng | - |
dc.relation.ispartof | Vaccine | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Burden of disease | - |
dc.subject | Cardiovascular events | - |
dc.subject | Comorbidity | - |
dc.subject | Complications | - |
dc.subject | Influenza virus | - |
dc.subject | Vaccination | - |
dc.title | The disease burden of influenza beyond respiratory illness | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1016/j.vaccine.2020.09.048 | - |
dc.identifier.pmid | 33041103 | - |
dc.identifier.pmcid | PMC7545338 | - |
dc.identifier.scopus | eid_2-s2.0-85092225370 | - |
dc.identifier.volume | 39 | - |
dc.identifier.issue | suppl. 1 | - |
dc.identifier.spage | A6 | - |
dc.identifier.epage | A14 | - |
dc.identifier.eissn | 1873-2518 | - |
dc.identifier.isi | WOS:000627802900002 | - |